BRPI0815595A2 - Composição antifúngica - Google Patents

Composição antifúngica

Info

Publication number
BRPI0815595A2
BRPI0815595A2 BRPI0815595-0A2A BRPI0815595A BRPI0815595A2 BR PI0815595 A2 BRPI0815595 A2 BR PI0815595A2 BR PI0815595 A BRPI0815595 A BR PI0815595A BR PI0815595 A2 BRPI0815595 A2 BR PI0815595A2
Authority
BR
Brazil
Prior art keywords
fungal composition
fungal
composition
Prior art date
Application number
BRPI0815595-0A2A
Other languages
English (en)
Inventor
Christian Bucher
Guenter Ditzinger
Estelle Dubois
Delphine Marchaud
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Publication of BRPI0815595A2 publication Critical patent/BRPI0815595A2/pt
Publication of BRPI0815595A8 publication Critical patent/BRPI0815595A8/pt
Publication of BRPI0815595B1 publication Critical patent/BRPI0815595B1/pt
Publication of BRPI0815595B8 publication Critical patent/BRPI0815595B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0815595A 2007-08-21 2008-08-20 composição antifúngica para administração oral, que é autoemulsificante em contato com uma fase aquosa, seu uso e produto farmacêutico BRPI0815595B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07114652.6 2007-08-21
EP07114652 2007-08-21
PCT/EP2008/060905 WO2009024590A2 (en) 2007-08-21 2008-08-20 Antifungal composition

Publications (4)

Publication Number Publication Date
BRPI0815595A2 true BRPI0815595A2 (pt) 2015-03-03
BRPI0815595A8 BRPI0815595A8 (pt) 2018-06-19
BRPI0815595B1 BRPI0815595B1 (pt) 2021-02-09
BRPI0815595B8 BRPI0815595B8 (pt) 2021-05-25

Family

ID=38656753

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0815595A BRPI0815595B8 (pt) 2007-08-21 2008-08-20 composição antifúngica para administração oral, que é autoemulsificante em contato com uma fase aquosa, seu uso e produto farmacêutico

Country Status (15)

Country Link
US (1) US8536208B2 (pt)
EP (1) EP2192893B1 (pt)
JP (1) JP5576279B2 (pt)
KR (1) KR101493546B1 (pt)
CN (1) CN101784259B (pt)
AU (1) AU2008290536B2 (pt)
BR (1) BRPI0815595B8 (pt)
CA (1) CA2697328C (pt)
ES (1) ES2551125T3 (pt)
HK (1) HK1141742A1 (pt)
MX (1) MX2010001730A (pt)
PL (1) PL2192893T3 (pt)
PT (1) PT2192893E (pt)
WO (1) WO2009024590A2 (pt)
ZA (1) ZA201000925B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX340815B (es) * 2011-12-02 2016-07-27 Colgate Palmolive Co Composicion de cuidado bucal que comprende isobutil magnolol.
PT3471702T (pt) * 2016-06-20 2022-03-17 Capretto Ehf Formulação termoestável de substâncias biologicamente ativas
CN105943500B (zh) * 2016-07-08 2019-01-04 河南省立眼科医院 一种含有艾沙康唑的眼用纳米胶束抗真菌溶液
WO2018219804A1 (en) * 2017-06-02 2018-12-06 Bayer Pharma Aktiengesellschaft Self-microemulsifying drug delivery systems
WO2023219465A1 (ko) * 2022-05-12 2023-11-16 주식회사 지뉴브 안정한 액상 제약 제제

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054136A (en) 1993-09-30 2000-04-25 Gattefosse S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
NZ270418A (en) 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
AU2931399A (en) 1998-03-06 1999-09-20 F. Hoffmann-La Roche Ag 3-(4-(4-cyanophenyl)thiazol-2-y))-1-(1h-1,2,4-triazol-1-yl) -butan-2-ol derivatives having antifungal activity
AU3843999A (en) * 1998-05-07 1999-11-23 Elan Corporation, Plc Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
WO2001032652A2 (en) 1999-11-02 2001-05-10 Basilea Pharmaceutica Ag N-substituted carbamoyloxyalkyl-azolium derivatives
JP2001302544A (ja) * 1999-12-10 2001-10-31 Takeda Chem Ind Ltd 経口用医薬組成物
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
FR2827770B1 (fr) 2001-07-27 2005-08-19 Gattefosse Ets Sa Composition pharmaceutique a usage oral comprenant un principe actif susceptible de subir un important effet de premier passage intestinal
US20050186142A1 (en) 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
EP1498123A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Emulsifying systems containing azetidine derivatives
FR2861992B1 (fr) * 2003-11-10 2007-07-20 Sanofi Synthelabo Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide.
US20070104740A1 (en) * 2003-12-23 2007-05-10 Voorspoels Jody Firmin M Self-microemulsifying drug delivery systems of a hiv protease inhibitor
FR2873585B1 (fr) * 2004-07-27 2006-11-17 Aventis Pharma Sa Nouvelles formulations galeniques de principes actifs
CN101065115A (zh) * 2004-11-24 2007-10-31 默克公司 取代酰胺的液体和半固体口服药物制剂
EA200800974A1 (ru) * 2005-09-29 2008-10-30 Репрос Терапьютикс Инк. Композиции с улучшенной биодоступностью, содержащие стероидное производное и полигликолизированный глицерид
WO2007056242A1 (en) * 2005-11-07 2007-05-18 Murty Pharmaceuticals, Inc. Improved delivery of tetrahydrocannabinol

Also Published As

Publication number Publication date
KR20100064370A (ko) 2010-06-14
US20110281918A1 (en) 2011-11-17
BRPI0815595B8 (pt) 2021-05-25
MX2010001730A (es) 2010-03-10
CN101784259B (zh) 2013-03-27
EP2192893B1 (en) 2015-08-19
CA2697328C (en) 2015-08-11
EP2192893A2 (en) 2010-06-09
WO2009024590A3 (en) 2009-06-04
JP2010536826A (ja) 2010-12-02
PT2192893E (pt) 2015-11-09
HK1141742A1 (en) 2010-11-19
BRPI0815595A8 (pt) 2018-06-19
CN101784259A (zh) 2010-07-21
ZA201000925B (en) 2010-10-27
KR101493546B1 (ko) 2015-02-16
ES2551125T3 (es) 2015-11-16
CA2697328A1 (en) 2009-02-26
WO2009024590A2 (en) 2009-02-26
AU2008290536A1 (en) 2009-02-26
US8536208B2 (en) 2013-09-17
PL2192893T3 (pl) 2015-12-31
BRPI0815595B1 (pt) 2021-02-09
AU2008290536B2 (en) 2012-02-09
JP5576279B2 (ja) 2014-08-20

Similar Documents

Publication Publication Date Title
NL301011I2 (nl) pegvaliase
LTC2140867I2 (lt) Farmacinė kompozicija
BRPI0813775A2 (pt) Composição
ATE528048T1 (de) Schweisshemmende/desodorierende zusammensetzung
BRPI0810634A2 (pt) Composições fungicidas
BRPI0721651A2 (pt) Composição farmacêutica
ATE542825T1 (de) Substituierte piperidino-dihydrothienopyrimidine
IT1392101B1 (it) Composizione comprendente isoflavoni
DE112008003636A5 (de) Mehrzuggruppierer
BRPI0810557A2 (pt) composição
BRPI0811274A2 (pt) Composição
DK2120884T3 (da) Farmaceutisk sammensætning
DK2125048T3 (da) Præparat
AT505058A3 (de) Türschliesssystem
BRPI0811002A2 (pt) Composição biofertilizante
DE602008005950D1 (de) Münzvereinzeler
FI20075844A (fi) Verkkopääsyautentikointi
BRPI0820960A2 (pt) composição
BRPI0816144A2 (pt) Composição
DK2190865T3 (da) Hypoallergent molekyle
DE112008003094A5 (de) Geomatte
DE502008003063D1 (de) Magnetventilinjektor
BRPI0815595A2 (pt) Composição antifúngica
BRPI0809270A2 (pt) Composição
DE602008006131D1 (de) Schussfadeneintragdüse

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 09/02/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/08/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF